Cellular sialoglycans are differentially required for endosomal and cell-surface entry of SARS-CoV-2 in lung cell lines is a research paper published in PLoS Pathogens (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Natural Sciences and Engineering Research Council of Canada Discovery Grant
Grant: RGPIN-2020-04277
Natural Sciences and Engineering Research Council of Canada Discovery Grant
Grant: RGPIN-2020-06748
Canadian Institutes of Health Research
Grant: 480708
Canadian Foundation for Innovation John R Evans Leaders Fund
Grant: 40081
Canadian Foundation for Innovation John R Evans Leaders Fund
Grant: 38408
Wellcome Trust
Grant: GB-CHC-210183
Medical Research Council
Grant: MC_PC_19060
nCoV: Developing CoV-bnMABs for therapy of highly pathogenic coronaviruses including SARS-CoV-2
Medical Research Council/National Institute for Health Research
Grant: MC_PC_20016
HICC: Humoral Immune Correlates for COVID19: Defining protective responses and critical readouts for Clinical Trials of Vaccines and Therapeutics
Wellcome Trust
Grant: 210183
Sex differences in macrophage dynamic behaviours
Natural Sciences and Engineering Research Council of Canada
Grant: unidentified
unidentified
J.P. Bickell Foundation
Vanier Canada Graduate Scholarship
Natural Sciences and Engineering Research Council of Canada - Postgraduate scholarship
Wellcome Trust
Banting Research Foundation
Queen's University
Wellcome Trust
FWCI
1.24
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals